CPT-11, Carbopplatin, Dexamethasone commbination chemotherapy for refractory aggressive lymphoma
Phase 2
Recruiting
- Conditions
- refactory aggressive lymphoma
- Registration Number
- JPRN-UMIN000004501
- Lead Sponsor
- Gunma Hematological Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1. anaphylasis foo\r carboplatin 2. diarrhea 3. ileus 4. peptic ulcer 5. interstitial pneumonitis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate
- Secondary Outcome Measures
Name Time Method adverse event